On Demand Education

Gene Expression Profile Testing To Resolve Diagnostic Ambiguity In Challenging Melanocytic Lesions

May 2023

Hadas Skupsky, M.D. FAAD

The Diagnostic Work-Up Of Ambiguous Melanocytic Lesions

Apr 2023

Etan Marks, DO

Integrating new technology into the management of non-dysplastic Barrett’s esophagus patients

Castle Biosciences hosted a case-based panel discussion at DDW 2023 highlighting how TissueCypher aids in the management of non-dysplastic Barrett’s esophagus patients.

Lipham J, Muthusamy R, Khara H

Individualized Risk Prediction in Barrett’s Esophagus

Jul 2016

Medical Laboratory Observer

Aaron DeWard

GNAQ and GNA11 mutations in uveal melanoma

Dec 2014

Melanoma Res 2014;24:525-34

Shoushtari AN and Carvajal RD

Genomic research in uveal melanoma

Retina Today 2010:67-9

Harbour JW

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death

Oct 2004

Cancer Res 2004;64:7205-9

Onken MD, Worley LA, Ehlers JP, et al.

Comprehensive Diagnostic Offering – Highly Accurate and Objective Tests for Melanocytic Lesions of Uncertain Potential

Learn About Castle’s Comprehensive Diagnostic Offering

Our suite of highly accurate tests for melanocytic lesions of uncertain potential increases diagnostic confidence and enables better clinical management plans for patients. Learn the essentials from this comprehensive introduction by Matthew Goldberg, MD, Medical Director for Castle Biosciences.

Matthew Goldberg, MD

A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett’s Esophagus

Feb 2017

Rebecca J. Critchley-Thorne

A Tissue Systems Pathology Assay for High-Risk Barrett’s Esophagus

May 2016

Rebecca J. Critchley-Thorne

A Cost-Effectiveness Analysis of an Adenocarcinoma Risk Prediction Multi-Biomarker Assay for Patients with Barrett’s Esophagus

Oct 2019

Gene expression profiling in uveal melanoma: five-year prospective outcomes and meta-analysis

Jul 2020

Aaberg TM, Covington KR, Tsai T, et al